Key Metrics of Incyte
Revenue$3.7B▲ 8.9% YoYFY 2023
Operating income$621M▲ 7.1% YoY
Net profit$598M▲ 75.4% YoY
Shareholders' equity$5.2B
Market cap$23.0BINCY · $113.44
Competitors10identified
About Incyte
Sectors
Company details
- Website
- incyte.com
- Listed
- Nasdaq: INCY
Operational Areas of Incyte
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameIncyte Corp.
TickerINCY
ExchangeNasdaq
CountryUnited States
SEC CIK0000879169
Listed since—
IndustryBiotechnology: Commercial Physical & Biological Resarch
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.incyte.com
US market & SEC filings
INCY · Nasdaq · SEC CIK 0000879169
Last price · 23 Oct 2026
$113.44
−2.72%
Market cap$23.0B
P/E42.8On FY 2023 diluted EPS
Volume1,405,106
SectorHealth CareBiotechnology: Commercial Physical & Biological Resarch
Country · IPOUnited States
INCY share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeWilmington
GSTIN—
Email—
Websitehttp://www.incyte.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Incyte
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.